CME
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Primary Care Module
August 03, 2023
Guest: James Galvin, MD, MPH, FANA Guest: Jon Toledo, MD, PhD Guest: Charles P. Vega, MD Recently, Alzheimers Disease (AD) saw its first approvals for disease modifying therapy (DMT). With amyloid-beta (A) targeting DMT now a reality,
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!